冠動脈疾患患者のためのデジタル化された心臓リハビリテーションプログラムの費用対効果
Justin Braver1,2,3, Thomas H Marwick1,3, Melinda J Carrington1,3
1Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Grattan Street, Parkville, Melbourne, VIC 3010, Australia.
European journal of preventive cardiology
|August 28, 2025
まとめ
デジタル化された心臓リハビリテーション (DeCR) は,冠動脈疾患の患者にとって費用対効果の高い戦略であり,健康上の結果を改善します. このデジタルアプローチは,通常のケアと比較して,よりよい品質調整寿命 (QALYs) を許容可能なコストで提供します.
科学分野:
- 心血管医学
- 健康 経済
- デジタル・ヘルス
背景:
- 冠動脈疾患 (CHD) は,効果的で手頃なリハビリテーションプログラムを必要とします.
- 伝統的な心臓リハビリテーションは 範囲とアデンスに制限があります
- デジタル化された心臓リハビリテーション (DeCR) は 患者への広範なアクセスを可能にする 解決策です
研究 の 目的:
- 慢性疾患の患者に対する全国的に実施された DeCR プログラムの長期的な費用対効果を評価する.
- DeCRの医療成果と費用を通常のケアと比較する.
主な方法:
- マルコフモデルを用いて費用対効果の分析を行った.
- 入院費用と介入の実施に関するデータも収集された.
- 品質調整寿命 (QALY) は,EQ-5D-5Lスコアと文献の推定から得られた.
- 年間3%の割引を適用した5年間の期間が適用された.
- 敏感性分析は,QALYあたり5万ドルという支払意向の値で実施された.
主要な成果:
- DeCRは4.677 QALYでAUD$121,235で,通常のケアでは3.244 QALYでAUD$100,733でした.
- 追加費用対効果比 (ICER) は,得られたQALYあたり14,302ドルで,WTPの値を下回った.
- DeCRはシミュレーションの87%で費用対効果があることが判明しました.
結論:
- デジタル化された心臓リハビリテーションは,通常治療の費用対効果の高い代替手段です.
- DeCRはQALYを含む健康成果を 受け入れられる経済的コストで改善します
- この発見は,DeCRプログラムのより広範な実施を支持します.
関連する概念動画
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23